May 14 (Reuters) - Carlyle Group (CG.O), opens new tab and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio (BLUE.O), opens new tab, the companies said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results